This report is patient safety work product generated within the SVS PSO, LLC, and is considered privileged and confidential.

Important Notes

  • All results are based on data entered into the VQI as of July 31, 2024. Any subsequent changes or updates to data after that date will not be reflected in this report.

  • Only cases submitted as complete in the PATHWAYS platform are reflected in this report.

  • Procedure timeframes and inclusion/exclusion criteria are given at the top of each report. Cases are also excluded if outcomes are missing or not enough data was entered to determine whether the case met inclusion/exclusion criteria.

  • Regions must have at least 3 centers with included cases for regional results to be displayed in tables and line charts.

  • Regions must have at least 3 centers with at least 10 included cases per center for regional results to be displayed in bar charts. It is therefore possible for a region’s results to be displayed in tables and line charts, but not in bar charts.

  • For risk-adjusted reports, regions must have at least 3 centers with at least 10 cases with complete data per center for regional results to be displayed in bar charts. It is therefore possible for a region’s results to be displayed in tables and line charts, but not in bar charts.

  • In all graphics, a p-value <.05 is considered statistically significant.

  • All graphics are interactive. Hover over a plot to view specific values. Select a section to zoom in on using your cursor (double-click to zoom back out). Click on an item in the legend to include/exclude it from the plot and double-click to isolate it. All plots can be downloaded individually using the camera icon in the top right corner of the plot.

  • Newly added or changed reports are indicated with italics .

Dashboard

The dashboard provides a high-level summarization of your center’s results for each of 38 reports, and gives both regional and VQI-wide benchmarks for comparison. The “Your Center” column gives the percentage of your center’s cases with the noted outcome. Numbers in parentheses give the number of cases with the outcome and the total number of cases meeting the inclusion criteria for that report. The “Your Region” and “VQI Overall” columns give the aggregate percentage of cases with the noted outcome, as well as the 10th, 25th, 50th (median), 75th, and 90th percentiles for centers in your region and VQI, respectively ([10th|25th|50th|75th|90th]). Your center’s results are highlighted blue if your center is in the “top” 25th percentile for VQI Overall, and coral if your center is in the “bottom” 25th percentile for VQI Overall.

Dashboard

Procedure Volume

Procedures performed between July 1, 2023 and June 30, 2024

Number of cases entered into the VQI, by registry and overall

Your Region (N) VQI Overall (N)
CAS (TFEM CAS & TCAR) 1034 25976
CEA 528 20184
EVAR 140 8202
HDA NA (<3 centers) 5513
INFRA 142 7094
IVCF NA (<3 centers) 876
LEAMP NA (<3 centers) 4048
OAAA 96 1385
PVI 2712 50744
SUPRA 46 2044
TEVAR 58 4599
Varicose Veins 2009 5942
Overall (July 2023-June 2024) 7043 136607
Overall (July 2022-June 2023) 7957 142387

Procedure Volume

31 of 33 centers displayed

Procedure Volume

Procedure Volume, All Years

Includes all procedures with procedure date through June 30, 2024

Number of cases entered into the VQI, by registry and overall

Your Region (N) VQI Overall (N)
CAS (TFEM CAS & TCAR) 4918 130780
CEA 5893 216665
EVAR 2282 88905
HDA 4115 81292
INFRA 3047 88159
IVCF 1025 19271
LEAMP NA (<3 centers) 32944
OAAA 995 19265
PVI 18391 428786
SUPRA 1026 27768
TEVAR 418 34035
Varicose Veins 20370 67135
Overall 63079 1235005

Procedure Volume, All Years

36 of 37 centers displayed

Procedure Volume, All Years

“Others” indicates centers that do not belong to a regional group.

Physician Specialties

Registry Subscriptions

Long-Term Follow-up

Procedures performed between July 1, 2021 and June 30, 2022

Includes CAS (TFEM CAS and TCAR), CEA, EVAR, HDA, INFRA, IVCF, LEAMP, OAAA, PVI, SUPRA, and TEVAR procedures only. Excludes procedures not eligible for long-term follow-up.

The table below gives the number of procedures meeting the inclusion criteria, and the percentage of those procedures with follow-up recorded between 9 and 21 months post-procedure.
Your Region VQI Overall
CAS 699 (83%) 18852 (69%)
CEA 359 (82%) 18665 (77%)
EVAR 184 (81%) 7967 (74%)
HDA NA (<3 centers) 6254 (70%)
INFRA 201 (82%) 6986 (77%)
IVCF NA (<3 centers) 1188 (77%)
LEAMP NA (<3 centers) 3233 (75%)
OAAA 80 (82%) 1354 (79%)
PVI 1950 (80%) 46309 (71%)
SUPRA 66 (73%) 2016 (76%)
TEVAR 20 (60%) 3560 (72%)
Overall (July 2021-June 2022) 4012 (82%) 116384 (73%)
Overall (July 2020-June 2021) 4151 (82%) 112072 (78%)

Long-Term Follow-up

Long-Term Follow-up

22 of 29 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

Long-Term Follow-up

Long-Term Follow-Up Unblinding Legend for Your Region
Index Medical Center Name Rate
1 MyMichigan Health - Midland 96.5%
2 McLaren Bay Region 95.8%
3 McLaren Greater Lansing 94.6%
4 Ascension Borgess Hospital 93.4%
5 Corewell Health Grand Rapids Hospitals - Butterworth 91.7%
6 Bronson Methodist Hospital 90.9%
7 Covenant Healthcare 89.4%
8 St. Mary Mercy Livonia 89.3%
9 Michigan Vascular Center 88.5%
10 Ascension St. John Hospital 88.5%
11 University of Michigan 85.4%
12 Munson Medical Center 85.0%
13 St. Joseph Mercy Health System 84.8%
14 Bronson Battlecreek Hospital 82.8%
15 Henry Ford Hospital, Detroit MI 80.7%
16 McLaren Port Huron 78.3%
17 Ascension St. Mary’s Hospital 66.7%
18 McLaren Northern Michigan 66.7%
19 McLaren Macomb 57.1%
20 Corewell Health William Beaumont University Hospital 52.7%
21 McLaren Flint 31.7%
22 Henry Ford Allegiance Health 14.6%

Long-Term Follow-up

“*” Indicates region’s rate differs significantly from the VQI rate.

Discharge Medications

Procedures performed between July 1, 2023 and June 30, 2024

Includes CAS (TFEM CAS and TCAR), CEA, EVAR, INFRA, LEAMP, OAAA, PVI, SUPRA, and TEVAR procedures only. Antiplatelet is defined as ASA or P2Y12 inhibitor. Cases are excluded if (1) Discharge Statin = “No, for medical reason” OR (2) Both Discharge ASA = “No, for medical reason” AND Discharge P2Y12 inhibitor = “No, for medical reason” OR (3) An in-hospital death occurred.

The table below gives the number of procedures meeting the inclusion criteria, and the percentage of those procedures where patients received discharge medications.
Number of Procedures Antiplatelet+Statin Antiplatelet Only Statin Only Neither
Your Region Overall 4557 90% 7% 3% 1%
VQI Overall 117357 88% 7% 3% 2%

Discharge Medications

Discharge Medications

30 of 32 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

Discharge Medications

“*” Indicates region’s rate differs significantly from the VQI rate.

Preop Smoking

Procedures performed between July 1, 2023 and June 30, 2024

Includes elective CAS (TFEM CAS and TCAR), CEA, EVAR, INFRA, LEAMP, OAAA, PVI, SUPRA, and TEVAR procedures only.

The table below gives the number of procedures meeting the inclusion criteria, and the percentage of those procedures where the patient was still smoking within one month of the procedure.
Your Region VQI Overall
CAS 849 (25%) 20794 (22%)
CEA 482 (27%) 17067 (23%)
EVAR 112 (28%) 6836 (31%)
INFRA 125 (30%) 5395 (37%)
LEAMP NA (<3 centers) 1615 (26%)
OAAA 81 (36%) 1035 (40%)
PVI 2368 (35%) 39470 (31%)
SUPRA 38 (55%) 1555 (51%)
TEVAR 47 (26%) 3242 (29%)
Overall (July 2023-June 2024) 4103 (32%) 97009 (28%)

Preop Smoking

Preop Smoking

29 of 32 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

Preop Smoking

“*” Indicates region’s rate differs significantly from the VQI rate.

Smoking Cessation at Follow-up

Procedures performed between July 1, 2021 and June 30, 2022

Includes CAS (TFEM CAS and TCAR), CEA, EVAR, HDA, INFRA, LEAMP, OAAA, PVI, SUPRA, and TEVAR procedures of any urgency status performed on patients smoking within one month of the procedure. Excludes procedures that do not have at least one long-term follow-up record where the patient’s follow-up smoking status was recorded.

The table below gives the number of procedures meeting the inclusion criteria, and the percentage of those procedures where the patient was not smoking within one month on follow-up for all long-term follow-up records where the patient’s follow-up smoking status was recorded.
Your Region VQI Overall
CAS 149 (40%) 2951 (35%)
CEA 68 (31%) 3505 (32%)
EVAR 66 (29%) 1751 (30%)
HDA NA (<3 centers) 438 (30%)
INFRA 75 (39%) 2030 (34%)
LEAMP NA (<3 centers) 535 (32%)
OAAA 21 (38%) 436 (32%)
PVI 523 (28%) 9703 (30%)
SUPRA 29 (28%) 798 (33%)
TEVAR 5 (20%) 689 (43%)
Overall (July 2021-June 2022) 982 (31%) 22836 (32%)

Smoking Cessation at Follow-up

Smoking Cessation at Follow-up

14 of 25 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

Smoking Cessation at Follow-up

“*” Indicates region’s rate differs significantly from the VQI rate.

TFEM CAS ASYMP: Stroke/Death

Procedures performed between July 1, 2023 and June 30, 2024

Includes Transfemoral Carotid Artery Stenting (TFEM CAS) procedures performed on asymptomatic patients. Asymptomatic patients are patients with no ipsilateral retinal or cortical TIA or stroke within 180 days prior to surgery. Includes procedures utilizing a femoral, brachial, or radial approach. Excludes any patient with prior vertebrobasilar TIA or stroke, prior ipsilateral CAS, CAS for intracranial treatment, or any procedure involving dissection, trauma, FMD, or “Other” lesion types. Procedures with an approach other than femoral, brachial, or radial are also excluded.

The table below gives the number of TFEM CAS procedures (performed on asymptomatic patients) meeting the inclusion criteria, and the observed and expected rates of in-hospital stroke or death for those cases.
Your Region VQI Overall
Number of TFEM CAS procedures meeting inclusion criteria 194 3677
Observed rate of stroke or death among procedures meeting inclusion criteria 0.5% 1.8%
Number of procedures with complete data* 171 3344
Observed rate of stroke or death among cases with complete data 0.6% 1.8%
Expected Rate of stroke or death among cases with complete data 1.8% NA
P-value for comparison of observed and expected rates 0.38 NA

*“Expected rate” is the rate estimated by a statistical model that accounts for patient characteristics, including age, gender, race, BMI, comorbidities, medication and stroke and vascular history. “Cases with complete data” include patients who have data on all of those factors.

TFEM CAS ASYMP: Stroke/Death

NCD change occurred in October 2023.

Rates shown are observed rates among cases meeting inclusion criteria.

TFEM CAS ASYMP: Stroke/Death

3 of 23 centers displayed

Rates shown are among cases with complete data.

“*” Indicates center’s observed rate differs significantly from its expected rate

TFEM CAS ASYMP: Stroke/Death

Rates shown are among cases with complete data.

“*” Indicates region’s observed rate differs significantly from its expected rate

TFEM CAS SYMP: Stroke/Death

Procedures performed between July 1, 2023 and June 30, 2024

Includes Transfemoral Carotid Artery Stenting (TFEM CAS) procedures performed on symptomatic patients. Symptomatic patients are patients with an ipsilateral retinal or cortical TIA or stroke within 180 days prior to surgery. Includes procedures utilizing a femoral, brachial, or radial approach. Excludes any patient with prior vertebrobasilar TIA or stroke, prior ipsilateral CAS, CAS for intracranial treatment, or any procedure involving dissection, trauma, FMD, or “Other” lesion types. Procedures with an approach other than femoral, brachial, or radial are also excluded.

The table below gives the number of TFEM CAS procedures (performed on symptomatic patients) meeting the inclusion criteria, and the observed and expected rates of in-hospital stroke or death for those cases.
Your Region VQI Overall
Number of TFEM CAS procedures meeting inclusion criteria 94 2359
Observed rate of stroke or death among procedures meeting inclusion criteria 4.3% 3.1%
Number of procedures with complete data* 84 2216
Observed rate of stroke or death among cases with complete data 4.8% 3.1%
Expected Rate of stroke or death among cases with complete data 3% NA
P-value for comparison of observed and expected rates 0.32 NA

*“Expected rate” is the rate estimated by a statistical model that accounts for patient characteristics, including age, gender, race, BMI, comorbidities, medication and stroke and vascular history. “Cases with complete data” include patients who have data on all of those factors.

TFEM CAS SYMP: Stroke/Death

NCD change occurred in October 2023.

Rates shown are observed rates among cases meeting inclusion criteria.

TFEM CAS SYMP: Stroke/Death

3 of 16 centers displayed

Rates shown are among cases with complete data.

“*” Indicates center’s observed rate differs significantly from its expected rate

TFEM CAS SYMP: Stroke/Death

Rates shown are among cases with complete data.

“*” Indicates region’s observed rate differs significantly from its expected rate

TCAR ASYMP: Stroke/Death

Procedures performed between July 1, 2023 and June 30, 2024

Includes TransCarotid Artery Revascularization (TCAR) procedures performed on asymptomatic patients. Asymptomatic patients are patients with no ipsilateral retinal or cortical TIA or stroke within 180 days prior to surgery. Excludes any patient with prior vertebrobasilar TIA or stroke, prior ipsilateral CAS, CAS for intracranial treatment, or any procedure involving dissection, trauma, FMD, or “Other” lesion types. Procedures with an approach other than carotid percutaneous or carotid open are also excluded.

The table below gives the number of TCAR procedures (performed on asymptomatic patients) meeting the inclusion criteria, and the observed and expected rates of in-hospital stroke or death for those cases.
Your Region VQI Overall
Number of TCAR procedures meeting inclusion criteria 396 11488
Observed rate of stroke or death among procedures meeting inclusion criteria 0.3% 1%
Number of procedures with complete data* 366 10616
Observed rate of stroke or death among cases with complete data 0.3% 1%
Expected Rate of stroke or death among cases with complete data 1% NA
P-value for comparison of observed and expected rates 0.28 NA

*“Expected rate” is the rate estimated by a statistical model that accounts for patient characteristics, including age, gender, race, BMI, comorbidities, medication and stroke and vascular history. “Cases with complete data” include patients who have data on all of those factors.

TCAR ASYMP: Stroke/Death

NCD change occurred in October 2023.

Rates shown are observed rates among cases meeting inclusion criteria.

TCAR ASYMP: Stroke/Death

14 of 27 centers displayed

Rates shown are among cases with complete data.

“*” Indicates center’s observed rate differs significantly from its expected rate

TCAR ASYMP: Stroke/Death

Rates shown are among cases with complete data.

“*” Indicates region’s observed rate differs significantly from its expected rate

TCAR SYMP: Stroke/Death

Procedures performed between July 1, 2023 and June 30, 2024

Includes TransCarotid Artery Revascularization (TCAR) procedures performed on symptomatic patients. Symptomatic patients are patients with an ipsilateral retinal or cortical TIA or stroke within 180 days prior to surgery. Excludes any patient with prior vertebrobasilar TIA or stroke, prior ipsilateral CAS, CAS for intracranial treatment, or any procedure involving dissection, trauma, FMD, or “Other” lesion types. Procedures with an approach other than carotid percutaneous or carotid open are also excluded.

The table below gives the number of TCAR procedures (performed on symptomatic patients) meeting the inclusion criteria, and the observed and expected rates of in-hospital stroke or death for those cases.
Your Region VQI Overall
Number of TCAR procedures meeting inclusion criteria 126 3667
Observed rate of stroke or death among procedures meeting inclusion criteria 4.8% 2.5%
Number of procedures with complete data* 122 3467
Observed rate of stroke or death among cases with complete data 4.9% 2.4%
Expected Rate of stroke or death among cases with complete data 2.4% NA
P-value for comparison of observed and expected rates 0.07 NA

*“Expected rate” is the rate estimated by a statistical model that accounts for patient characteristics, including age, gender, race, BMI, comorbidities, medication and stroke and vascular history. “Cases with complete data” include patients who have data on all of those factors.

TCAR SYMP: Stroke/Death

NCD change occurred in October 2023.

Rates shown are observed rates among cases meeting inclusion criteria.

TCAR SYMP: Stroke/Death

4 of 21 centers displayed

Rates shown are among cases with complete data.

“*” Indicates center’s observed rate differs significantly from its expected rate

TCAR SYMP: Stroke/Death

Rates shown are among cases with complete data.

“*” Indicates region’s observed rate differs significantly from its expected rate

CEA ASYMP: Stroke/Death

Procedures performed between July 1, 2023 and June 30, 2024

Includes Carotid Endarterectomy (CEA) procedures performed on asymptomatic patients. Asymptomatic patients are patients with no ipsilateral retinal or cortical TIA or stroke within 180 days prior to surgery. Excludes any patient with prior vertebrobasilar or non-specific TIA or stroke, prior ipsilateral CEA or CAS, or any procedure with a concomitant CABG, proximal endovascular, distal endovascular, or “Other” arterial procedure.

The table below gives the number of CEA procedures (performed on asymptomatic patients) meeting the inclusion criteria, and the observed and expected rates of in-hospital stroke or death for those cases.
Your Region VQI Overall
Number of CEA procedures meeting inclusion criteria 316 11991
Observed rate of stroke or death among procedures meeting inclusion criteria 0.6% 1%
Number of procedures with complete data* 257 10530
Observed rate of stroke or death among cases with complete data 0.8% 0.9%
Expected Rate of stroke or death among cases with complete data 0.8% NA
P-value for comparison of observed and expected rates 1 NA

*“Expected rate” is the rate estimated by a statistical model that accounts for patient characteristics, including age, gender, race, BMI, comorbidities, medication and stroke and vascular history. “Cases with complete data” include patients who have data on all of those factors.

CEA ASYMP: Stroke/Death

Rates shown are observed rates among cases meeting inclusion criteria.

CEA ASYMP: Stroke/Death

10 of 14 centers displayed

Rates shown are among cases with complete data.

“*” Indicates center’s observed rate differs significantly from its expected rate

CEA ASYMP: Stroke/Death

Rates shown are among cases with complete data.

“*” Indicates region’s observed rate differs significantly from its expected rate

CEA ASYMP: Postop LOS>1 Day

Procedures performed between July 1, 2023 and June 30, 2024

Includes Carotid Endarterectomy (CEA) procedures performed on asymptomatic patients. Asymptomatic patients are patients with no ipsilateral retinal or cortical TIA or stroke within 180 days prior to surgery. Excludes any patient with prior vertebrobasilar or non-specific TIA or stroke, prior ipsilateral CEA or CAS, or any procedure with a concomitant CABG, proximal endovascular, distal endovascular, or “Other” arterial procedure. Procedures where in-hospital death occurred with postoperative LOS≤1 day, or procedures with an unrelated return to the OR, are also excluded. Postoperative LOS is based on the midnight rule used for hospital billing.

The table below gives the number of CEA procedures (performed on asymptomatic patients) meeting the inclusion criteria, and the observed and expected rates of postoperative LOS>1 Day for those cases.
Your Region VQI Overall
Number of CEA procedures meeting inclusion criteria 315 11929
Observed rate of LOS>1 day among procedures meeting inclusion criteria 25.4% 22.7%
Number of procedures with complete data* 256 10470
Observed rate of LOS>1 day among cases with complete data 23.4% 22.4%
Expected Rate of LOS>1 day among cases with complete data 21.1% NA
P-value for comparison of observed and expected rates 0.36 NA

*“Expected rate” is the rate estimated by a statistical model that accounts for patient characteristics, including age, gender, race, BMI, comorbidities, medication and stroke and vascular history. “Cases with complete data” include patients who have data on all of those factors.

CEA ASYMP: Postop LOS>1 Day

Rates shown are observed rates among cases meeting inclusion criteria.

CEA ASYMP: Postop LOS>1 Day

10 of 14 centers displayed

Rates shown are among cases with complete data.

“*” Indicates center’s observed rate differs significantly from its expected rate

CEA ASYMP: Postop LOS>1 Day

Rates shown are among cases with complete data.

“*” Indicates region’s observed rate differs significantly from its expected rate

CEA SYMP: Stroke/Death

Procedures performed between July 1, 2023 and June 30, 2024

Includes Carotid Endarterectomy (CEA) procedures performed on symptomatic patients. Symptomatic patients are patients with an ipsilateral retinal or cortical TIA or stroke within 180 days prior to surgery. Excludes any patient with prior vertebrobasilar or non-specific TIA or stroke, prior ipsilateral CEA or CAS, or any procedure with a concomitant CABG, proximal endovascular, distal endovascular, or “Other” arterial procedure.

The table below gives the number of CEA procedures (performed on symptomatic patients) meeting the inclusion criteria, and the observed and expected rates of in-hospital stroke or death for those cases.
Your Region VQI Overall
Number of CEA procedures meeting inclusion criteria 125 5559
Observed rate of stroke or death among procedures meeting inclusion criteria 1.6% 1.8%
Number of procedures with complete data* 113 4894
Observed rate of stroke or death among cases with complete data 0.9% 1.7%
Expected Rate of stroke or death among cases with complete data 1.5% NA
P-value for comparison of observed and expected rates 1 NA

*“Expected rate” is the rate estimated by a statistical model that accounts for patient characteristics, including age, gender, race, BMI, comorbidities, medication and stroke and vascular history. “Cases with complete data” include patients who have data on all of those factors.

CEA SYMP: Stroke/Death

Rates shown are observed rates among cases meeting inclusion criteria.

CEA SYMP: Stroke/Death

0 of 13 centers displayed

Rates shown are among cases with complete data.

“*” Indicates center’s observed rate differs significantly from its expected rate

CEA SYMP: Stroke/Death

Rates shown are among cases with complete data.

“*” Indicates region’s observed rate differs significantly from its expected rate

CEA SYMP: Postop LOS>1 Day

Procedures performed between July 1, 2023 and June 30, 2024

Includes Carotid Endarterectomy (CEA) procedures performed on symptomatic patients. Symptomatic patients are patients with an ipsilateral retinal or cortical TIA or stroke within 180 days prior to surgery. Excludes any patient with prior vertebrobasilar or non-specific TIA or stroke, prior ipsilateral CEA or CAS, or any procedure with a concomitant CABG, proximal endovascular, distal endovascular, or “Other” arterial procedure. Procedures where in-hospital death occurred with postoperative LOS≤1 day, or procedures with an unrelated return to the OR, are also excluded. Postoperative LOS is based on the midnight rule used for hospital billing.

The table below gives the number of CEA procedures (performed on symptomatic patients) meeting the inclusion criteria, and the observed and expected rates of postoperative LOS>1 Day for those cases.
Your Region VQI Overall
Number of CEA procedures meeting inclusion criteria 124 5525
Observed rate of LOS>1 day among procedures meeting inclusion criteria 38.7% 41.1%
Number of procedures with complete data* 112 4867
Observed rate of LOS>1 day among cases with complete data 41.1% 41.1%
Expected Rate of LOS>1 day among cases with complete data 40.9% NA
P-value for comparison of observed and expected rates 1 NA

*“Expected rate” is the rate estimated by a statistical model that accounts for patient characteristics, including age, gender, race, BMI, comorbidities, medication and stroke and vascular history. “Cases with complete data” include patients who have data on all of those factors.

CEA SYMP: Postop LOS>1 Day

Rates shown are observed rates among cases meeting inclusion criteria.

CEA SYMP: Postop LOS>1 Day

0 of 13 centers displayed

Rates shown are among cases with complete data.

“*” Indicates center’s observed rate differs significantly from its expected rate

CEA SYMP: Postop LOS>1 Day

Rates shown are among cases with complete data.

“*” Indicates region’s observed rate differs significantly from its expected rate

EVAR: Postop LOS>2 Days

Procedures performed between July 1, 2023 and June 30, 2024

Includes elective Endovascular AAA Repair (EVAR) procedures. Excludes any procedure with ruptured aneurysm. Procedures where in-hospital death occurred with postoperative LOS≤2 days are also excluded. Postoperative LOS is based on the midnight rule used for hospital billing.

The table below gives the number of EVAR procedures meeting the inclusion criteria, and the observed and expected rates of postoperative LOS>2 Days for those cases.
Your Region VQI Overall
Number of EVAR procedures meeting inclusion criteria 112 6829
Observed rate of LOS>2 days among procedures meeting inclusion criteria 15.2% 12%
Number of procedures with complete data* 103 6326
Observed rate of LOS>2 days among cases with complete data 14.6% 11.9%
Expected Rate of LOS>2 days among cases with complete data 12.3% NA
P-value for comparison of observed and expected rates 0.45 NA

*“Expected rate” is the rate estimated by a statistical model that accounts for patient characteristics, including age, gender, race, BMI, comorbidities, medication and stroke and vascular history. “Cases with complete data” include patients who have data on all of those factors.

EVAR: Postop LOS>2 Days

Rates shown are observed rates among cases meeting inclusion criteria.

EVAR: Postop LOS>2 Days

4 of 4 centers displayed

Rates shown are among cases with complete data.

“*” Indicates center’s observed rate differs significantly from its expected rate

EVAR: Postop LOS>2 Days

Rates shown are among cases with complete data.

“*” Indicates region’s observed rate differs significantly from its expected rate

EVAR: Sac Diameter Reporting

Procedures performed between July 1, 2021 and June 30, 2022

Includes Endovascular AAA Repair (EVAR) procedures. Excludes patients who were converted to open or died within 21 months of surgery.

The table below gives the number of EVAR procedures meeting the inclusion criteria, and the percentage of those procedures where a sac diameter was reported between 9 and 21 months post-procedure.
Your Region VQI Overall
Number of EVAR procedures meeting inclusion criteria 169 7300
Percentage with sac diameter reported between 9 and 21 months post-procedure 71.6% 58.8%

EVAR: Sac Diameter Reporting

EVAR: Sac Diameter Reporting

4 of 4 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

EVAR: Sac Diameter Reporting

“*” Indicates region’s rate differs significantly from the VQI rate.

EVAR: SVS AAA Diameter Guideline

Procedures performed between July 1, 2023 and June 30, 2024

Includes Endovascular AAA Repair (EVAR) procedures. Excludes any non-elective procedure. SVS AAA diameter guideline is ≥5 cm for Women and ≥5.5cm for men. If the patient has any iliac aneurysm, the guideline is considered met regardless of AAA diameter.

The table below gives the number of EVAR procedures meeting the inclusion criteria, and the percentage of those procedures meeting the SVS AAA diameter guideline.
Your Region VQI Overall
Number of EVAR procedures meeting inclusion criteria 111 6774
Percentage meeting SVS AAA diameter guideline 91% 76%

EVAR: SVS AAA Diameter Guideline

EVAR: SVS AAA Diameter Guideline

4 of 4 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

EVAR: SVS AAA Diameter Guideline

“*” Indicates region’s rate differs significantly from the VQI rate.

TEVAR: Sac Diameter Reporting

Procedures performed between July 1, 2021 and June 30, 2022

Includes Thoracic Endovascular Aortic Repair (TEVAR) procedures for aneurysm or aneurysm from dissection. Excludes procedures where no aortic device was implanted or patients who were converted to open or died within 21 months of surgery.

The table below gives the number of TEVAR procedures meeting the inclusion criteria, and the percentage of those procedures where a sac diameter was reported between 9 and 21 months post-procedure.
Your Region VQI Overall
Number of TEVAR procedures meeting inclusion criteria 14 1830
Percentage with sac diameter reported between 9 and 21 months post-procedure 50% 62.3%

TEVAR: Sac Diameter Reporting

TEVAR: Sac Diameter Reporting

0 of 3 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

TEVAR: Sac Diameter Reporting

“*” Indicates region’s rate differs significantly from the VQI rate.

OAAA: In-Hospital Mortality

Procedures performed between July 1, 2020 and June 30, 2024

Includes Open AAA (OAAA) procedures. Excludes any patient with a ruptured aneurysm.

The table below gives the number of OAAA procedures meeting the inclusion criteria, and the observed and expected rates of in-hospital death for those cases.
Your Region VQI Overall
Number of OAAA procedures meeting inclusion criteria 362 4994
Observed rate of In-Hospital Mortality among procedures meeting inclusion criteria 3.3% 3.7%
Number of procedures with complete data* 346 4708
Observed rate of In-Hospital Mortality among cases with complete data 3.5% 3.4%
Expected Rate of In-Hospital Mortality among cases with complete data 3.7% NA
P-value for comparison of observed and expected rates 1 NA

*“Expected rate” is the rate estimated by a statistical model that accounts for patient characteristics, including age, gender, race, BMI, comorbidities, medication and stroke and vascular history. “Cases with complete data” include patients who have data on all of those factors.

OAAA: In-Hospital Mortality

Rates shown are observed rates among cases meeting inclusion criteria.

OAAA: In-Hospital Mortality

4 of 5 centers displayed

Rates shown are among cases with complete data.

“*” Indicates center’s observed rate differs significantly from its expected rate

OAAA: In-Hospital Mortality

Rates shown are among cases with complete data.

“*” Indicates region’s observed rate differs significantly from its expected rate

OAAA: SVS Cell-Saver Guideline

Procedures performed between July 1, 2020 and June 30, 2024

Includes Open AAA (OAAA) procedures. Excludes any patient with EBL≤500 ml. SVS cell-saver guideline is met if cell salvage or ultrafiltration device was used.

The table below gives the number of OAAA procedures meeting the inclusion criteria, and the percentage of those procedures meeting the SVS cell-saver guideline.
Your Region VQI Overall
Number of OAAA procedures meeting inclusion criteria 343 4984
Percentage meeting SVS cell-saver guideline 83.7% 93.3%

OAAA: SVS Cell-Saver Guideline

OAAA: SVS Cell-Saver Guideline

4 of 5 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

OAAA: SVS Cell-Saver Guideline

“*” Indicates region’s rate differs significantly from the VQI rate.

PVI CLAUD: ABI/Toe Pressure

Procedures performed between July 1, 2023 and June 30, 2024

Includes Peripheral Vascular Intervention (PVI) procedures for mild, moderate, or severe claudication. “ABI/Toe Pressure Assessment” indicates at least one ABI or toe pressure assessment was made prior to PVI for the side of the procedure, or on both sides for bilateral and aortic procedures.

The table below gives the number of PVI procedures meeting the inclusion criteria, and the percentage of those procedures in which an ABI or toe pressure was assessed prior to PVI.
Your Region VQI Overall
Number of PVI procedures meeting inclusion criteria 1080 15941
Percentage with ABI/toe pressure assessment 61.3% 66.6%

PVI CLAUD: ABI/Toe Pressure

PVI CLAUD: ABI/Toe Pressure

17 of 18 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

PVI CLAUD: ABI/Toe Pressure

“*” Indicates region’s rate differs significantly from the VQI rate.

PVI CLAUD: Preop Smoking

Procedures performed between July 1, 2023 and June 30, 2024

Includes Peripheral Vascular Intervention (PVI) procedures for mild, moderate, or severe claudication.

The table below gives the number of PVI procedures meeting the inclusion criteria, and the percentage of those procedures where the patient was smoking within one month of the procedure.
Your Center Your Region VQI Overall
Number of PVI procedures meeting inclusion criteria 1080 15937
Percentage smoking at time of procedure 37.3% 36%

PVI CLAUD: Preop Smoking

Rates shown are observed rates among cases meeting inclusion criteria.

PVI CLAUD: Preop Smoking

17 of 18 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

PVI CLAUD: Preop Smoking

“*” Indicates region’s rate differs significantly from the VQI rate.

PVI: Follow-up Symptom Improvement

Procedures performed between July 1, 2021 and June 30, 2022

Includes Peripheral Vascular Intervention (PVI) procedures for Claudcation (mild, moderate, or severe) or CLTI (tissue loss, ischemic rest pain, ulcer/necrosis, non-healing amputation, acute ischemia). Symptom improvement is defined as leg symptoms for the treated side(s) = ‘Asymptomatic’ for all long-term follow-up records .

The table below gives the number of PVI procedures meeting the inclusion criteria, and the percentage of those procedures asymptomatic at follow-up overall and seperated by symptom status at the time of procedure.
Your Center Your Region VQI Overall
Number of PVI procedures meeting inclusion criteria 1304 26695
Percentage with symptom improvement at follow-up 69.9% 72.4%
Percentage claudication to asymptomatic 29.0% 29.3%
Percentage CLTI to asymptomatic 41.0% 43.1%

PVI: Follow-up Symptom Improvement

Rates shown are observed rates among cases meeting inclusion criteria.

PVI: Follow-up Symptom Improvement

10 of 15 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

PVI: Follow-up Symptom Improvement

“*” Indicates region’s rate differs significantly from the VQI rate.

PVI CLAUD: Follow-up ReTX or Major Amputation

Procedures performed between July 1, 2021 and June 30, 2022

Includes Peripheral Vascular Intervention (PVI) procedures for mild, moderate, or severe claudication. Long-term follow-up re-interventions include endovascular, surgical, or both for the treated artery. Long-term follow-up major amputations include those above, below, or through the knee on the treated leg.

The table below gives the number of PVI procedures meeting the inclusion criteria, and the percentage of those procedures with a re-intervention or major amputation on follow-up.
Your Center Your Region VQI Overall
Number of PVI procedures meeting inclusion criteria 515 9718
Percentage with re-intervention or major amputation at follow-up 19% 13.2%
Percentage with endovascular re-intervention at follow-up 0.8% 1.0%
Percentage with surgical re-intervention at follow-up 14.6% 10.4%
Percentage with major amputation at follow-up 4.7% 2.4%

PVI CLAUD: Follow-up ReTX or Major Amputation

Rates shown are observed rates among cases meeting inclusion criteria.

PVI CLAUD: Follow-up ReTX or Major Amputation

8 of 11 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

PVI CLAUD: Follow-up ReTX or Major Amputation

“*” Indicates region’s rate differs significantly from the VQI rate.

PVI CLTI: Follow-up ReTX or Major Amputation

Procedures performed between July 1, 2021 and June 30, 2022

Includes Peripheral Vascular Intervention (PVI) procedures for CLTI (tissue loss, ischemic rest pain, ulcer/necrosis, non-healing amputation, acute ischemia). Long-term follow-up re-interventions include endovascular, surgical, or both for the treated artery. Long-term follow-up major amputations include those above, below, or through the knee on the treated leg.

The table below gives the number of PVI procedures meeting the inclusion criteria, and the percentage of those procedures with a re-intervention or major amputation on follow-up.
Your Center Your Region VQI Overall
Number of PVI procedures meeting inclusion criteria 784 14887
Percentage with re-intervention or major amputation at follow-up 31.8% 28.7%
Percentage with endovascular re-intervention at follow-up 13.1% 10.8%
Percentage with surgical re-intervention at follow-up 17.3% 17.4%
Percentage with major amputation at follow-up 5.2% 3.7%

PVI CLTI: Follow-up ReTX or Major Amputation

Rates shown are observed rates among cases meeting inclusion criteria.

PVI CLTI: Follow-up ReTX or Major Amputation

10 of 15 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

PVI CLTI: Follow-up ReTX or Major Amputation

“*” Indicates region’s rate differs significantly from the VQI rate.

INFRA: ABI/Toe Pressure

Procedures performed between July 1, 2023 and June 30, 2024

Includes Infrainguinal Bypass (INFRA) procedures. “ABI/Toe Pressure Assessment” indicates at least one ABI, TcPO2, or toe pressure assessment was made prior to Infrainguinal surgery for the treated side. Excludes emergent cases.

The table below gives the number of INFRA procedures meeting the inclusion criteria, and the percentage of those procedures where at least one ABI or toe pressure assessment was made prior to Infrainguinal surgery
Your Center Your Region VQI Overall
Number of INFRA procedures meeting inclusion criteria 139 6833
Percentage with ABI/toe pressure assessment 72.7% 70%

INFRA: ABI/Toe Pressure

Rates shown are observed rates among cases meeting inclusion criteria.

INFRA: ABI/Toe Pressure

4 of 5 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

INFRA: ABI/Toe Pressure

“*” Indicates region’s rate differs significantly from the VQI rate.

INFRA CLAUD: RTOR

Procedures performed between July 1, 2023 and June 30, 2024

Includes Infrainguinal Bypass (INFRA) procedures for mild, moderate, or severe claudication. Includes patients Return To OR (RTOR) for thrombosis, revision, or any major amputation (planned or unplanned). “Other” includes RTOR for bleeding and infection. Note that “Other” RTOR cases are excluded from the overall rate.

The table below gives the number of INFRA procedures meeting the inclusion criteria, and the percentage of those procedures with return to OR for the given reasons.
Your Region VQI Overall
Number of INFRA procedures meeting inclusion criteria 22 1,010
Percentage of INFRA with RTOR 0.0% 3.6%
Percentage of INFRA with RTOR for Thrombosis 0.0% 2.5%
Percentage of INFRA with RTOR for Revision 0.0% 1.9%
Percentage of INFRA with RTOR for Major Amputation 0.0% 1.3%
Other (bleeding, infection) 4.5% 0.8%

INFRA CLAUD: RTOR

Rates shown are observed rates among cases meeting inclusion criteria.

INFRA CLAUD: RTOR

0 of 5 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

INFRA CLAUD: RTOR

“*” Indicates region’s rate differs significantly from the VQI rate.

INFRA CLTI: RTOR

Procedures performed between July 1, 2023 and June 30, 2024

Includes Infrainguinal Bypass (INFRA) procedures for rest pain, tissue loss (i.e., ulcer, necrosis, or non-healing amputation), or acute ischemia. Includes patients Return To OR (RTOR) for thrombosis, revision, or unplanned amputation. “Other” includes RTOR for bleeding, infection, or planned amputation. Note that “Other” RTOR cases are excluded from the overall rate.

The table below gives the number of INFRA procedures meeting the inclusion criteria, and the percentage of those procedures with return to OR for the given reasons.
Your Region VQI Overall
Number of INFRA procedures meeting inclusion criteria 110 5,483
Percentage of INFRA with RTOR 5.5% 6.1%
Percentage of INFRA with RTOR for Thrombosis 1.8% 3.3%
Percentage of INFRA with RTOR for Revision 0.9% 2.5%
Percentage of INFRA with RTOR for Unplanned Amputation 2.7% 2.5%
Other (bleeding, infection, planned amputation) 4.5% 12.2%

INFRA CLTI: RTOR

Rates shown are observed rates among cases meeting inclusion criteria.

INFRA CLTI: RTOR

4 of 4 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

INFRA CLTI: RTOR

“*” Indicates region’s rate differs significantly from the VQI rate.

INFRA CLTI: WIfI

Procedures performed between July 1, 2023 and June 30, 2024

Includes Infrainguinal Bypass (INFRA) procedures for tissue loss (i.e., ulcer, necrosis, and/or non-healing amputation). WIfI documentation includes the following variables: ABI or toe pressure, tissue loss grade, and infection grade for the treated side. Excludes cases with urgency status of emergent. Excludes cases with urgency status of emergent.

The table below gives the number of INFRA procedures meeting the inclusion criteria, and the percentage of those procedures with WIfI variables documented for the treated side.
Your Center Your Region VQI Overall
Number of INFRA procedures meeting inclusion criteria 69 3213
Percentage with WIfI variables documented 82.6% 69.9%

INFRA CLTI: WIfI

Rates shown are observed rates among cases meeting inclusion criteria.

INFRA CLTI: WIfI

3 of 4 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

INFRA CLTI: WIfI

“*” Indicates region’s rate differs significantly from the VQI rate.

SUPRA: ABI/Toe Pressure

Procedures performed between July 1, 2023 and June 30, 2024

Includes Suprainguinal Bypass (SUPRA) procedures. “ABI/Toe Pressure Assessment” indicates at least one ABI, TcPO2, or toe pressure assessment was made prior to Suprainguinal surgery for the treated side. Excludes emergent cases.

The table below gives the number of SUPRA procedures meeting the inclusion criteria, and the percentage of those procedures where at least one ABI or toe pressure assessment was made prior to Suprainguinal surgery
Your Center Your Region VQI Overall
Number of supra procedures meeting inclusion criteria 43 1941
Percentage with ABI/toe pressure assessment 79.1% 68.6%

SUPRA: ABI/Toe Pressure

Rates shown are observed rates among cases meeting inclusion criteria.

SUPRA: ABI/Toe Pressure

0 of 4 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

SUPRA: ABI/Toe Pressure

“*” Indicates region’s rate differs significantly from the VQI rate.

SUPRA CLAUD: RTOR

Procedures performed between July 1, 2023 and June 30, 2024

Includes Suprainguinal Bypass (SUPRA) procedures for mild, moderate, or severe claudication. Includes patients Return To OR (RTOR) for thrombosis, revision, or any major amputation. “Other” includes RTOR for bleeding and infection. Note that “Other” RTOR cases are excluded from the overall rate.

The table below gives the number of SUPRA procedures meeting the inclusion criteria, and the percentage of those procedures with return to OR for the given reasons.
Your Region VQI Overall
Number of SUPRA procedures meeting inclusion criteria 16 663
Percentage of SUPRA with RTOR 0.0% 2.0%
Percentage of SUPRA with RTOR for Thrombosis 0.0% 1.4%
Percentage of SUPRA with RTOR for Revision 0.0% 1.1%
Percentage of SUPRA with RTOR for Major Amputation 0.0% 0.6%
Other (bleeding, infection) 0.0% 2.0%

SUPRA CLAUD: RTOR

Rates shown are observed rates among cases meeting inclusion criteria.

SUPRA CLAUD: RTOR

0 of 3 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

SUPRA CLAUD: RTOR

“*” Indicates region’s rate differs significantly from the VQI rate.

SUPRA CLTI: RTOR

Procedures performed between July 1, 2023 and June 30, 2024

Includes Suprainguinal Bypass (SUPRA) procedures for rest pain, tissue loss (i.e., ulcer, necrosis, or non-healing amputation), or acute ischemia. Includes patients Return To OR (RTOR) for thrombosis, revision, or unplanned amputation. “Other” includes RTOR for bleeding, infection, or planned amputation. Note that “Other” RTOR cases are excluded from the overall rate.

The table below gives the number of SUPRA procedures meeting the inclusion criteria, and the percentage of those procedures with return to OR for the given reasons.
Your Region VQI Overall
Number of SUPRA procedures meeting inclusion criteria 28 1,278
Percentage of SUPRA with RTOR 3.6% 4.5%
Percentage of SUPRA with RTOR for Thrombosis 3.6% 2.3%
Percentage of SUPRA with RTOR for Revision 3.6% 2.0%
Percentage of SUPRA with RTOR for Unplanned Amputation 0.0% 1.4%
Other (bleeding, infection, planned amputation) 3.6% 6.2%

SUPRA CLTI: RTOR

Rates shown are observed rates among cases meeting inclusion criteria.

SUPRA CLTI: RTOR

0 of 4 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

SUPRA CLTI: RTOR

“*” Indicates region’s rate differs significantly from the VQI rate.

SUPRA CLTI: WIfI

Procedures performed between July 1, 2023 and June 30, 2024

Includes Suprainguinal Bypass (SUPRA) procedures for tissue loss (i.e., ulcer, necrosis, and/or non-healing amputation) with documented ABI or Toe Pressure value, tissue loss grade, and infection grade for the treated side. Excludes cases with urgency status of emergent.

The table below gives the number of SUPRA procedures meeting the inclusion criteria, and the percentage of those procedures with WIfI variables documented for the treated side.
Your Center Your Region VQI Overall
Number of supra procedures meeting inclusion criteria NA (<3 centers) 276
Percentage with WIfI variables documented 65.2%

SUPRA CLTI: WIfI

Rates shown are observed rates among cases meeting inclusion criteria.

SUPRA CLTI: WIfI

0 of 2 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

SUPRA CLTI: WIfI

“*” Indicates region’s rate differs significantly from the VQI rate.

LEAMP: Postop Complications

Procedures performed between July 1, 2023 and June 30, 2024

Includes Lower-Extremity Amputation (LEAMP) procedures. Postoperative complications are defined as myocardial infarction, dysrhythmia, congestive heart failure, surgical site infection, renal complication, or respiratory complication.

The table below gives the number of LEAMP procedures meeting the inclusion criteria, and the percentage of those procedures that resulted in a postoperative complication.
Your Region VQI Overall
Number of LEAMP procedures meeting inclusion criteria NA (<3 centers) 4044
Percentage with postoperative complications 11.9%

LEAMP: Postop Complications

LEAMP: Postop Complications

0 of 1 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

LEAMP: Postop Complications

“*” Indicates region’s rate differs significantly from the VQI rate.

HDA: Primary AVF vs. Graft

Procedures performed between July 1, 2023 and June 30, 2024

Includes Hemodialysis Access (HDA) procedures. Excludes procedures where Access Type = Endo AVF or patients with a previous access procedure in the same arm.

The table below gives the number of HDA procedures meeting the inclusion criteria, and the percentage of those procedures that were primary AVF. Additionally, the number of HDA procedures not autogenous with associated reasons are also shown.
Your Region VQI Overall
Number of HDA procedures meeting inclusion criteria NA (<3 centers) 4491
Percentage with primary AVF 83.1%
Number of HDA procedures not autogenous NA (<3 centers) 757
Percentage needs acute access 4.6%
Percentage vein not available 75.8%
Percentage limited life expectency 0.9%
Percentage morbid obesity 0.9%
Percentage body habitus 0.3%
Percentage patient preference 1.5%
Percentage unstable arterial anatomy 2.0%
Percentage central venous pathology 3.8%
Percentage other, documented 5.4%
Percentage not specified 12.4%
Percentage missing 0.1%

HDA: Primary AVF vs. Graft

HDA: Primary AVF vs. Graft

0 of 1 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

HDA: Primary AVF vs. Graft

“*” Indicates region’s rate differs significantly from the VQI rate.

HDA: Ultrasound Vein Mapping

Procedures performed between July 1, 2023 and June 30, 2024

Includes Hemodialysis Access (HDA) procedures.

The table below gives the number of HDA procedures meeting the inclusion criteria, and the percentage of those procedures with preoperative ultrasound vein mapping.
Your Region VQI Overall
Number of HDA procedures meeting inclusion criteria NA (<3 centers) 5503
Percentage with preoperative ultrasound vein mapping 86.1%

HDA: Ultrasound Vein Mapping

HDA: Ultrasound Vein Mapping

0 of 1 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

HDA: Ultrasound Vein Mapping

“*” Indicates region’s rate differs significantly from the VQI rate.

HDA: Postop Complications

Procedures performed between July 1, 2023 and June 30, 2024

Includes Hemodialysis Access (HDA) procedures.

The table below gives the number of HDA procedures meeting the inclusion criteria, and the percentage of those procedures that resulted in an immediate postoperative complication. Postoperative complications are defined as bleeding, ischemic steal, ischemic monomelic neuropathy, access thrombosis, or other complication requiring reoperation.
Your Region VQI Overall
Number of HDA procedures meeting inclusion criteria NA (<3 centers) 5506
Percentage with immediate postoperative complications 1.3%

HDA: Postop Complications

HDA: Postop Complications

0 of 1 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

HDA: Postop Complications

“*” Indicates region’s rate differs significantly from the VQI rate.

IVCF: Filter Retrieval Reporting

Procedures performed between July 1, 2021 and June 30, 2022

Includes Inferior Vena Cava Filter (IVCF) procedures. Excludes filters with permanent planned duration, patients who have expired, or patients where no follow-up was possible.

The table below gives the number of procedures meeting the inclusion criteria, and the percentage of those procedures in which the filter was reported as retrieved (or retrieval was attempted) at any time post-procedure. Because follow-up is critical for assessing filter retrieval, cases meeting the inclusion criteria are broken down into those with follow-up records (at least 1 follow-up record) and those without follow-up records.
Your Region VQI Overall
Number of IVCF procedures meeting inclusion criteria NA (<3 centers) 771
Number without follow-up records 153
Number with follow-up records 618
Percentage with Filter Retrieval, or Attempt at Retrieval 51.5%
Percentage not retrieved because No Follow-up Records Created 19.8%
Percentage not retrieved because Not Clinically Indicated 19.8%
Percentage not retrieved because Patient Declined 1.9%
Percentage not retrieved because Lost to Follow-Up 3.2%
Percentage not retrieved because Deemed Too Late for Removal 0.4%
Percentage not retrieved because Planned Later Removal 3.1%
Percentage not retrieved because No Reason Given 0.6%

IVCF: Filter Retrieval Reporting

IVCF: Filter Retrieval Reporting

0 of 1 centers displayed

“*” Indicates center’s rate differs significantly from the regional rate.

IVCF: Filter Retrieval Reporting

“*” Indicates region’s rate differs significantly from the VQI rate.

Region Volume Appendix

The Region Volume Appendix provides your region’s case volumes for each report. In addition, the number of centers with cases contributing to each report is given. Note that columns referencing complete cases are appropriately left blank for non risk-adjusted reports.